يعرض 1 - 20 نتائج من 53,514 نتيجة بحث عن '"Immune Checkpoint inhibitors"', وقت الاستعلام: 0.70s تنقيح النتائج
  1. 1
    Academic Journal
    Tivozanib plus nivolumab versus tivozanib monotherapy in patients with renal cell carcinoma following an immune checkpoint inhibitor: results of the phase 3 TiNivo-2 Study.

    المؤلفون: Choueiri, Toni K1 (AUTHOR) toni_choueiri@dfci.harvard.edu, Albiges, Laurence1,2 (AUTHOR), Barthélémy, Philippe3 (AUTHOR), Iacovelli, Roberto4 (AUTHOR), Emambux, Sheik5 (AUTHOR), Molina-Cerrillo, Javier6 (AUTHOR), Garmezy, Benjamin7 (AUTHOR), Barata, Pedro8,9 (AUTHOR), Basu, Arnab10 (AUTHOR), Bourlon, Maria T11 (AUTHOR), Moon, Helen12 (AUTHOR), Ratta, Raffaele13 (AUTHOR), McKay, Rana R14 (AUTHOR), Chehrazi-Raffle, Alexander15 (AUTHOR), Hammers, Hans16 (AUTHOR), Heng, Daniel Y C17 (AUTHOR), Braendle, Edgar18 (AUTHOR), Beckermann, Kathryn E19 (AUTHOR), McGregor, Bradley A1 (AUTHOR), Motzer, Robert J1,20 (AUTHOR)

    المصدر: Lancet. Oct2024, Vol. 404 Issue 10460, p1309-1320. 12p.

    مصطلحات موضوعية: VASCULAR endothelial growth factor receptors, IMMUNE checkpoint inhibitors, CLINICAL trials, PROTEIN-tyrosine kinase inhibitors, RENAL cell carcinoma, PROGRESSION-free survival


    أضف إلى المفضلة
  2. 2
    Academic Journal
    Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study

    المؤلفون: Lordick, F.1 (AUTHOR) florian.lordick@medizin.uni-leipzig.de, Mauer, M.E.2 (AUTHOR), Stocker, G.1 (AUTHOR), Cella, C.A.3 (AUTHOR), Ben-Aharon, I.4 (AUTHOR), Piessen, G.5 (AUTHOR), Wyrwicz, L.6 (AUTHOR), Al-Haidari, G.7 (AUTHOR), Fleitas-Kanonnikoff, T.8 (AUTHOR), Boige, V.9 (AUTHOR), Lordick Obermannová, R.10 (AUTHOR), Martens, U.M.11 (AUTHOR), Gomez-Martin, C.12 (AUTHOR), Thuss-Patience, P.13 (AUTHOR), Arrazubi, V.14 (AUTHOR), Avallone, A.15 (AUTHOR), Shiu, K.K.16 (AUTHOR), Artru, P.17 (AUTHOR), Brenner, B.18 (AUTHOR), Buges Sanchez, C.19 (AUTHOR)

    المصدر: Annals of Oncology. Feb2025, Vol. 36 Issue 2, p197-207. 11p.

    مصطلحات موضوعية: *ESOPHAGOGASTRIC junction cancer, *IMMUNE checkpoint inhibitors, *ADJUVANT chemotherapy, *NEOADJUVANT chemotherapy, *SURGICAL margin


    أضف إلى المفضلة
  3. 3
    Academic Journal
    Enhancing the tissue penetration to improve sonodynamic immunotherapy for pancreatic ductal adenocarcinoma using membrane-camouflaged nanoplatform.

    المؤلفون: Du, Jiawei1 (AUTHOR), Chen, Xin1,2 (AUTHOR), Xu, Xiaoxuan1 (AUTHOR), Que, Ziting3 (AUTHOR), Zhai, Mengyan3 (AUTHOR), Xiang, Qinyanqiu1 (AUTHOR), Zhang, Zhiwei1 (AUTHOR), Zhang, Zhiqi1 (AUTHOR), Shao, Yong3 (AUTHOR), Yang, Xue1 (AUTHOR), Miao, Fengqin3 (AUTHOR), Zhang, Jianqiong1,3 (AUTHOR), Xie, Jinbing1 (AUTHOR) xiejb@seu.edu.cn, Ju, Shenghong1 (AUTHOR) jsh@seu.edu.cn

    المصدر: European Journal of Nuclear Medicine & Molecular Imaging. Feb2025, Vol. 52 Issue 3, p1119-1136. 18p.

    مصطلحات موضوعية: *MEDICAL sciences, *IMMUNE checkpoint inhibitors, *PANCREATIC duct, *IMMUNE checkpoint proteins, *ACOUSTIC imaging, *CYTOTOXIC T cells


    أضف إلى المفضلة
  4. 4
    Academic Journal
    Outcomes in the Asian subgroup of the phase III randomised HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma.

    المؤلفون: Lau, George1 (AUTHOR), Abou-Alfa, Ghassan K.1,2,3 (AUTHOR) abou-alg@MSKCC.ORG, Cheng, Ann-Lii4 (AUTHOR), Sukeepaisarnjaroen, Wattana5 (AUTHOR), Van Dao, Tu6 (AUTHOR), Kang, Yoon Koo7 (AUTHOR), Thungappa, Satheesh Chiradoni8 (AUTHOR), Kudo, Masatoshi9 (AUTHOR), Sangro, Bruno10 (AUTHOR), Kelley, Robin Kate11 (AUTHOR), Furuse, Junji12 (AUTHOR), Park, Joong-Won13 (AUTHOR), Sunpaweravong, Patrapim14 (AUTHOR), Fasolo, Angelica15 (AUTHOR), Yau, Thomas16 (AUTHOR), Kawaoka, Tomokazu17 (AUTHOR), Azevedo, Sergio18 (AUTHOR), Reig, Maria19 (AUTHOR), Assenat, Eric20 (AUTHOR), Yarchoan, Mark21 (AUTHOR)

    المصدر: Journal of Hepatology. Feb2025, Vol. 82 Issue 2, p258-267. 10p.

    مصطلحات موضوعية: *IMMUNE checkpoint inhibitors, *ADVERSE health care events, *OVERALL survival, *HEPATOCELLULAR carcinoma, WESTERN countries


    أضف إلى المفضلة
  5. 5
    Academic Journal
    IDO1 inhibitor enhances the effectiveness of PD-1 blockade in microsatellite stable colorectal cancer by promoting macrophage pro-inflammatory phenotype polarization.

    المؤلفون: Guangzhao, Lv1,2 (AUTHOR), Xin, Wang3 (AUTHOR), Miaoqing, Wu1,2,4 (AUTHOR), Wenjuan, Ma1,5 (AUTHOR), Ranyi, Liu1 (AUTHOR), Zhizhong, Pan1,2 (AUTHOR) panzhzh@sysucc.org.cn, Rongxin, Zhang1,2 (AUTHOR) zhangrx@sysucc.org.cn, Gong, Chen1,2 (AUTHOR) chengong@sysucc.org.cn

    المصدر: Cancer Immunology, Immunotherapy. Feb2025, Vol. 74 Issue 2, p1-14. 14p.

    مصطلحات موضوعية: *MEDICAL sciences, *IMMUNE checkpoint inhibitors, *PROGRAMMED cell death 1 receptors, *COLORECTAL cancer, *CANCER cells

    Full Text Finder

    أضف إلى المفضلة
  6. 6
    Academic Journal
    First-line immune-based combinations or sunitinib in favorable-risk metastatic renal cell carcinoma: a real-world retrospective comparison from the ARON-1 study.

    المؤلفون: Roviello, Giandomenico1 (AUTHOR), Molina-Cerrillo, Javier2,3 (AUTHOR) javier.molinace@gmail.com, Massari, Francesco4,5 (AUTHOR), Cerbone, Linda6 (AUTHOR), Fiala, Ondrej7,8 (AUTHOR), Fornarini, Giuseppe9 (AUTHOR), Monteiro, Fernando Sabino Marques10,11 (AUTHOR), Cattrini, Carlo12 (AUTHOR), Landmesser, Johannes13 (AUTHOR), Messina, Carlo14 (AUTHOR), Zgura, Anca15 (AUTHOR), Rebuzzi, Sara Elena16,17 (AUTHOR), Soares, Andrey10,18 (AUTHOR), Carrozza, Francesco19 (AUTHOR), Ansari, Jawaher20 (AUTHOR), Grillone, Francesco21 (AUTHOR), Küronya, Zsófia22 (AUTHOR), Incorvaia, Lorena23 (AUTHOR), Bhuva, Dipen24 (AUTHOR), Ortega, Cinzia25 (AUTHOR)

    المصدر: Cancer Immunology, Immunotherapy. Feb2025, Vol. 74 Issue 2, p1-11. 11p.

    مصطلحات موضوعية: *IMMUNE checkpoint inhibitors, *RENAL cell carcinoma, *BONE metastasis, *PROTEIN-tyrosine kinase inhibitors, *SUNITINIB

    Full Text Finder

    أضف إلى المفضلة
  7. 7
    Academic Journal
    Fractionated low-dose radiotherapy primes the tumor microenvironment for immunotherapy in a murine mesothelioma model.

    المؤلفون: D'Alonzo, Rebecca A.1,2,3 (AUTHOR) rebecca.dalonzo@uwa.edu.au, Keam, Synat2,3,4 (AUTHOR), Gill, Suki1,4,5 (AUTHOR), Rowshanfarzad, Pejman1 (AUTHOR), Nowak, Anna K.2,3,4 (AUTHOR), Ebert, Martin A.1,5 (AUTHOR), Cook, Alistair M.2,3,6 (AUTHOR) alistair.cook@uwa.edu.au

    المصدر: Cancer Immunology, Immunotherapy. Feb2025, Vol. 74 Issue 2, p1-16. 16p.

    مصطلحات موضوعية: *REGULATORY T cells, *IMMUNE checkpoint inhibitors, *TUMOR-infiltrating immune cells, *MEDICAL sciences, *DOPPLER ultrasonography

    Full Text Finder

    أضف إلى المفضلة
  8. 8
    Academic Journal
    Sex differences in immunotherapy outcomes and tumor-infiltrating immune cell profiles in patients with advanced renal cell carcinoma.

    المؤلفون: Ishihara, Hiroki1 (AUTHOR), Fukuda, Hironori1 (AUTHOR) fukuda.hironori@twmu.ac.jp, Mizoguchi, Yukihiro2 (AUTHOR), Yamashita, Makiko2,3 (AUTHOR), Aoki, Kazunori2 (AUTHOR), Ishiyama, Ryo1,4 (AUTHOR), Ikeda, Takashi1 (AUTHOR), Nemoto, Yuki1,5 (AUTHOR), Shimmura, Hiroaki5 (AUTHOR), Hashimoto, Yasunobu6 (AUTHOR), Yoshida, Kazuhiko1 (AUTHOR), Hirai, Toshihito1 (AUTHOR), Iizuka, Junpei1 (AUTHOR), Tokita, Daisuke1 (AUTHOR), Kondo, Tsunenori7 (AUTHOR), Nagashima, Yoji8 (AUTHOR), Takagi, Toshio1 (AUTHOR)

    المصدر: Cancer Immunology, Immunotherapy. Feb2025, Vol. 74 Issue 2, p1-10. 10p.

    مصطلحات موضوعية: *TUMOR-infiltrating immune cells, *IMMUNE checkpoint inhibitors, *RENAL cell carcinoma, *MEDICAL sciences, *PATIENTS

    Full Text Finder

    أضف إلى المفضلة
  9. 9
    Academic Journal
    CMV IgG in the blood is not associated with hepatitis but correlates with poor outcomes in immunotherapy treated melanoma patients.

    المؤلفون: Strobel, Sophia B.1 (AUTHOR), Machiraju, Devayani1,2 (AUTHOR), Wiecken, Melanie1,2,3 (AUTHOR), Richter, Jasmin1 (AUTHOR), Klein, Julian A. F.4 (AUTHOR), Berger, Annemarie5 (AUTHOR), Hassel, Jessica C.1 (AUTHOR) Jessica.Hassel@med.uni-heidelberg.de

    المصدر: Cancer Immunology, Immunotherapy. Feb2025, Vol. 74 Issue 2, p1-10. 10p.

    مصطلحات موضوعية: *BLOOD cell count, *IMMUNE checkpoint inhibitors, *MEDICAL sciences, *CLINICAL immunology, *CANCER patients

    Full Text Finder

    أضف إلى المفضلة
  10. 10
    Academic Journal
    Differential diagnosis in immune checkpoint inhibitors neurotoxicity.

    المؤلفون: Garcia, Catherine R.1 (AUTHOR) cgarcia18@mdanderson.org, Robertson, Ian J.2 (AUTHOR), Gregory, Timothy A.3 (AUTHOR), Zahid, Anza4 (AUTHOR), Amini, Behrang5 (AUTHOR), Kamiya-Matsuoka, Carlos1 (AUTHOR), Tummala, Sudhakar1 (AUTHOR)

    المصدر: Journal of Neurology. Feb2025, Vol. 272 Issue 2, p1-10. 10p.

    مصطلحات موضوعية: *VITAMIN B12 deficiency, *IMMUNE checkpoint inhibitors, *MOTOR neuron diseases, *CARPAL tunnel syndrome, *CENTRAL nervous system


    أضف إلى المفضلة
  11. 11
    Academic Journal
    Tumor-associated-fibrosis and active collagen-CD44 axis characterize a poor-prognosis subtype of gastric cancer and contribute to tumor immunosuppression.

    المؤلفون: Yang, Yingqi1 (AUTHOR), Sun, Haohan1 (AUTHOR), Yu, Hongkai1 (AUTHOR), Wang, Luyao1 (AUTHOR), Gao, Chang1 (AUTHOR), Mei, Haokun2 (AUTHOR), Jiang, Xiaomeng3 (AUTHOR) jxmroy@hotmail.com, Ji, Minghui4 (AUTHOR) jiminghui@njmu.edu.cn

    المصدر: Journal of Translational Medicine. 1/27/2025, Vol. 23 Issue 1, p1-16. 16p.

    مصطلحات موضوعية: *REGULATORY T cells, *IMMUNE checkpoint inhibitors, *STOMACH cancer, *MEDICAL sciences, *IMMUNE checkpoint proteins

    Full Text Finder

    أضف إلى المفضلة
  12. 12
    Academic Journal
    Effect of probiotics combined with immune checkpoint suppressors and chemotherapeutic agents on digestive system function, intestinal immunity and prognosis in patients with metastatic colorectal carcinoma: a quasi-experimental study.

    المؤلفون: Wang, Xiaolei1 (AUTHOR) wangxiaolei1224@sohu.com, Huang, Yuxia2 (AUTHOR) 231045970@qq.com, Yang, Zhen1 (AUTHOR) 2523025731@qq.com, Yang, Yang1 (AUTHOR) 209777421@qq.com, Wei, Fenfen1 (AUTHOR) 19584251@qq.com, Yan, Min1 (AUTHOR) 603377877@qq.com, Li, Fanfan1 (AUTHOR) zhongliukewxl@163.com, Wang, Chenghao3 (AUTHOR) 175806940@qq.com

    المصدر: BMC Gastroenterology. 1/27/2025, Vol. 25 Issue 1, p1-10. 10p.

    مصطلحات موضوعية: *INTESTINAL barrier function, *IMMUNE checkpoint inhibitors, *COLORECTAL cancer, *IMMUNE checkpoint proteins, *APPETITE loss

    Full Text Finder

    أضف إلى المفضلة
  13. 13
    Academic Journal
    Identification of Epinastine as CD96/PVR inhibitor for cancer immunotherapy.

    المؤلفون: Zhang, Xiangrui1 (AUTHOR) zhangxiangrui0304@163.com, Zhang, Lihan2 (AUTHOR) 13909421681@163.com, Li, Beibei1 (AUTHOR) lbbb0921@163.com, Wang, Qingchao1 (AUTHOR) a1554653969@163.com, Chen, Peixin1 (AUTHOR) chenpeixin12004@163.com, Shi, Ranran3 (AUTHOR) ranranpeptide@163.com, Zhou, Xiuman4 (AUTHOR) zhouxm36@mail.sysu.edu.cn, Niu, Xiaoshuang4 (AUTHOR) nxs0204@163.com, Zhai, Wenjie1,5 (AUTHOR) wjzhai@zzu.edu.cn, Wu, Yahong1,5 (AUTHOR) yahongwu@zzu.edu.cn, Shen, Wenhui6 (AUTHOR) 18317894496@163.com, Zhou, Xiaowen1 (AUTHOR) zhouxw@zzu.edu.cn, Zhao, Wenshan1 (AUTHOR) zhaowsh07@zzu.edu.cn

    المصدر: BMC Biology. 1/27/2025, Vol. 23 Issue 1, p1-15. 15p.

    مصطلحات موضوعية: *IMMUNE checkpoint inhibitors, *KILLER cells, *MEDICAL sciences, *VIRTUAL high-throughput screening (Drug development), *TUMOR growth, *T cells

    Full Text Finder

    أضف إلى المفضلة
  14. 14
    Academic Journal
    Correlates of Cetuximab Efficacy in Recurrent and Metastatic Head and Neck Squamous Cell Carcinoma Previously Treated With Immunotherapy.

    المؤلفون: Park, Jong Chul1,2 (AUTHOR), Ahn, Jong Seok3 (AUTHOR), Merkin, Ross1,2 (AUTHOR), Patel, Manisha1,2 (AUTHOR), Wirth, Lori1,2 (AUTHOR), Roberts, Thomas J.1,2 (AUTHOR) thomas.roberts@mgh.harvard.edu

    المصدر: JCO Precision Oncology. 1/27/2025, Vol. 9, p1-9. 9p.

    مصطلحات موضوعية: *IMMUNE checkpoint inhibitors, *SQUAMOUS cell carcinoma, *PATIENT selection, *COMBINATION drug therapy, *OVERALL survival


    أضف إلى المفضلة
  15. 15
    Academic Journal
    Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study.

    المؤلفون: Majidova, Nargiz1 (AUTHOR) nergiz.mecidova1991@gmail.com, Arak, Hacı2 (AUTHOR), Ozalp, Faruk Recep3 (AUTHOR), Bas, Onur4 (AUTHOR), Koker, Gulhan Ozcelik5 (AUTHOR), Ozmarasalı, Erkan Buket6 (AUTHOR), Karateke, Yasemin Sagdıc7 (AUTHOR), Sakalar, Teoman8 (AUTHOR), Yaslikaya, Sendag9 (AUTHOR), Onur, Ilknur Deliktas10 (AUTHOR), Akdag, Goncagul11 (AUTHOR), Ogul, Ali12 (AUTHOR), Guliyev, Murad13 (AUTHOR), Sahin, Elif14 (AUTHOR), Delipoyraz, Ebru Engin15 (AUTHOR), Alkan, Ali16 (AUTHOR), Aydın, Okan17 (AUTHOR), Ilhan, Nurullah18 (AUTHOR), Alan, Ozkan19 (AUTHOR), Akbas, Sinem19 (AUTHOR)

    المصدر: Scientific Reports. 1/25/2025, Vol. 15 Issue 1, p1-8. 8p.

    مصطلحات موضوعية: *IMMUNE checkpoint inhibitors, *MEDICAL sciences, *PROGNOSIS, *ADJUVANT chemotherapy, *OVERALL survival, *DACARBAZINE, *PROGRESSION-free survival

    Full Text Finder

    أضف إلى المفضلة
  16. 16
    Academic Journal
    Bilateral Choroidal Metastases from Primary Cutaneous Melanoma Following Nivolumab Discontinuation: A Case Report.

    المؤلفون: Padilla-Pantoja, Fabio Daniel1 (AUTHOR) fdpadillap@unal.edu.co, Godin, Fernando2 (AUTHOR), Rojas-Rojas, Fernando3 (AUTHOR), Camargo-González, Jennifer3 (AUTHOR), Ancona-Lezama, David4 (AUTHOR)

    المصدر: Ocular Immunology & Inflammation. Jan2025, p1-4. 4p. 3 Illustrations.

    مصطلحات موضوعية: *IMMUNE checkpoint inhibitors, *TERMINATION of treatment, *VISION, *INTERSTITIAL nephritis, *INTRAOCULAR pressure


    أضف إلى المفضلة
  17. 17
    Academic Journal
    Analysis of Pleiotropic Effects of Nivolumab in Patients with Relapsed Pleural Mesothelioma: A Single-Center Retrospective Study.

    المؤلفون: Higashiyama, Tomoki1 (AUTHOR), Kuribayashi, Kozo1 (AUTHOR) kuririn@hyo-med.ac.jp, Doi, Hiroshi2 (AUTHOR), Kubota, Aki1 (AUTHOR), Otsuki, Taiichiro1 (AUTHOR), Nakajima, Yasuhiro1 (AUTHOR), Mikami, Koji1 (AUTHOR), Takahashi, Ryo1 (AUTHOR), Nakamura, Akifumi3 (AUTHOR), Fujimoto, Daichi1 (AUTHOR), Kitajima, Kazuhiro4 (AUTHOR), Minami, Toshiyuki1 (AUTHOR), Kijima, Takashi1 (AUTHOR)

    المصدر: Oncology. Jan2025, p1-10. 10p. 6 Illustrations.

    مصطلحات موضوعية: *IMMUNE checkpoint inhibitors, *ADVERSE health care events, *OVERALL survival, *PROGRESSION-free survival, *NIVOLUMAB


    أضف إلى المفضلة
  18. 18
    Academic Journal
    Efficacy analysis of drug-eluting beads transcatheter arterial chemoembolization combining systemic chemotherapy and immune checkpoint inhibitors in unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study based on propensity score matching

    المؤلفون: Song, Liu1,2 (AUTHOR), Qingdong, Wang2 (AUTHOR), Shunhang, Yin3 (AUTHOR), Long, Li2 (AUTHOR), Guangsheng, Zhao3 (AUTHOR) zhongliujieru2023@163.com, Guangji, Yu2 (AUTHOR) 531641406@qq.com, Dong, Wang1,4 (AUTHOR) wangdongdlzxyy@163.com

    المصدر: World Journal of Surgical Oncology. 1/24/2025, Vol. 23 Issue 1, p1-12. 12p.

    مصطلحات موضوعية: *CANCER chemotherapy, *IMMUNE checkpoint inhibitors, *TREATMENT effectiveness, *CHEMOEMBOLIZATION, *PROPORTIONAL hazards models

    Full Text Finder

    أضف إلى المفضلة
  19. 19
    Academic Journal
    A literature review of recent advances in gastric cancer treatment: exploring the cross-talk between targeted therapies.

    المؤلفون: Panahizadeh, Reza1,2 (AUTHOR), Panahi, Padideh3 (AUTHOR), Asghariazar, Vahid1 (AUTHOR), Makaremi, Shima1 (AUTHOR), Noorkhajavi, Ghasem1 (AUTHOR), Safarzadeh, Elham1,4 (AUTHOR) Elham.im63@gmail.com

    المصدر: Cancer Cell International. 1/24/2025, Vol. 25 Issue 1, p1-20. 20p.

    مصطلحات موضوعية: *IMMUNE checkpoint inhibitors, *MEDICAL sciences, *CANCER vaccines, *TREATMENT effectiveness, *TUMOR microenvironment

    Full Text Finder

    أضف إلى المفضلة
  20. 20
    Academic Journal
    Organ-specific immune-related adverse events and prognosis in cancer patients receiving immune checkpoint inhibitors.

    المؤلفون: Han, Xinyue1,2 (AUTHOR), Chen, Yingcui1,2 (AUTHOR), Xie, Hong1,2 (AUTHOR), Zhang, Yuekai1,2 (AUTHOR), Cui, Yu1,2 (AUTHOR), Guan, Yaping1,2 (AUTHOR), Nie, Weiwei1,2 (AUTHOR), Xie, Qi1,2 (AUTHOR), Li, Jisheng3 (AUTHOR), Wang, Baocheng4 (AUTHOR), Zhang, Bicheng5 (AUTHOR), Wang, Jun1,2 (AUTHOR) ggjun2005@126.com

    المصدر: BMC Cancer. 1/24/2025, Vol. 25 Issue 1, p1-12. 12p.

    مصطلحات موضوعية: *DRUG side effects, *IMMUNE checkpoint inhibitors, *ADVERSE health care events, *CANCER prognosis, *MEDICAL sciences

    Full Text Finder

    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS – أرسل هذا البحث بالبريد الإلكتروني – حفظ البحث – جدول التنبيهات: لا شيء